D. Fuchs

发表

US and MRI of gastrointestinal graft-versus-host disease

W. Kaiser, H. Mentzel, H. Kosmehl, 2002, Pediatric Radiology.

T-cell independent production of salivary secretory IgA after hematopoietic stem cell transplantation in children.

B. Gruhn, F. Zintl, J. Hermann, 2005, Oral microbiology and immunology.

Comparison of allogeneic and autologous bone marrow transplantation for treatment of acute lymphocytic leukemia in childhood.

F. Zintl, J. Hermann, G. Metzner, 1990, Haematology and blood transfusion.

Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood

H. Kosmehl, B. Gruhn, F. Zintl, 1998, Bone Marrow Transplantation.

Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML

B. Gruhn, F. Zintl, K. Dawczynski, 2006, Bone Marrow Transplantation.

Renal function after conditioning therapy for bone marrow transplantation in childhood.

M. Debroe, F. Zintl, M. Brandis, 1997, Medical and pediatric oncology.

Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial

F. Zintl, M. Brandis, K. Kentouche, 2001, Bone Marrow Transplantation.

Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005

B. Meissner, K. Welte, L. Grigull, 2009, Bone Marrow Transplantation.

Somnolence Syndrome after Total Body Irradiation in Children with Bone Marrow Transplantation

J. Hermann, D. Fuchs, R. Zintl, 2001 .

Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15‐month‐old child

B. Gruhn, F. Zintl, J. Geoghegan, 2002, Pediatric transplantation.

[Correction of fatal genetic diseases using bone marrow transplantation. 1].

F. Zintl, J. Hermann, J. Füller, 1991, Kinderarztliche Praxis.

Transplantation of major AB0-incompatible bone marrow: removal of red cells by dextrane sedimentation.

F. Zintl, J. Hermann, E. Burger, 1989, Folia haematologica.

[Correction of fatal genetic diseases using bone marrow transplantation. 2].

F. Zintl, J. Hermann, J. Füller, 1991, Kinderarztliche Praxis.

Improved treatment results in childhood acute nonlymphoblastic leukemia with the BFM-AML protocol 78 in a multicenter study in the GDR.

F. Zintl, H. Malke, J. Hermann, 1987, Haematology and blood transfusion.

Comparison of Allogeneic and Autologous Bone Marrow Transplantation for Treatment of Childhood Acute Myeloblastic Leukemia (AML) in First Complete Remission

F. Zintl, J. Hermann, J. Füller, 1996 .

Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia

B. Meissner, W. Friedrich, A. Borkhardt, 2007, Bone Marrow Transplantation.

Successful treatment of essential thrombocythemia with anagrelide in a child.

F. Zintl, J. Hermann, A. Sauerbrey, 1998, Medical and pediatric oncology.

Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis

B. Gruhn, F. Zintl, D. Berger, 2003, Bone Marrow Transplantation.

[Procalcitonin in comparison to C-reactive protein as markers of the course of sepsis in severely immunocompromised children after bone marrow transplantation].

F. Zintl, R. Volland, D. Fuchs, 2000, Klinische Padiatrie.